Literature DB >> 21472593

Qualitative metabolome analysis of human cerebrospinal fluid by 13C-/12C-isotope dansylation labeling combined with liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry.

Kevin Guo1, Fiona Bamforth, Liang Li.   

Abstract

Metabolome analysis of human cerebrospinal fluid (CSF) is challenging because of low abundance of metabolites present in a small volume of sample. We describe and apply a sensitive isotope labeling LC-MS technique for qualitative analysis of the CSF metabolome. After a CSF sample is divided into two aliquots, they are labeled by (13)C-dansyl and (12)C-dansyl chloride, respectively. The differentially labeled aliquots are then mixed and subjected to LC-MS using Fourier-transform ion cyclotron resonance mass spectrometry (FTICR MS). Dansylation offers significant improvement in the performance of chromatography separation and detection sensitivity. Moreover, peaks detected in the mass spectra can be readily analyzed for ion pair recognition and database search based on accurate mass and/or retention time information. It is shown that about 14,000 features can be detected in a 25-min LC-FTICR MS run of a dansyl-labeled CSF sample, from which about 500 metabolites can be profiled. Results from four CSF samples are compared to gauge the detectability of metabolites by this method. About 261 metabolites are commonly detected in replicate runs of four samples. In total, 1132 unique metabolite ion pairs are detected and 347 pairs (31%) matched with at least one metabolite in the Human Metabolome Database. We also report a dansylation library of 220 standard compounds and, using this library, about 85 metabolites can be positively identified. Among them, 21 metabolites have never been reported to be associated with CSF. These results illustrate that the dansylation LC-FTICR MS method can be used to analyze the CSF metabolome in a more comprehensive manner. © American Society for Mass Spectrometry, 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472593     DOI: 10.1007/s13361-010-0033-4

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  33 in total

Review 1.  Biomarkers for neurodegenerative diseases.

Authors:  Susie M D Henley; Gillian P Bates; Sarah J Tabrizi
Journal:  Curr Opin Neurol       Date:  2005-12       Impact factor: 5.710

2.  Ionizable isotopic labeling reagent for relative quantification of amine metabolites by mass spectrometry.

Authors:  Michael R Shortreed; Shane M Lamos; Brian L Frey; Margaret F Phillips; Madhusudan Patel; Peter J Belshaw; Lloyd M Smith
Journal:  Anal Chem       Date:  2006-09-15       Impact factor: 6.986

Review 3.  Metabolomics: a global biochemical approach to drug response and disease.

Authors:  Rima Kaddurah-Daouk; Bruce S Kristal; Richard M Weinshilboum
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

4.  The human cerebrospinal fluid metabolome.

Authors:  David S Wishart; Michael J Lewis; Joshua A Morrissey; Mitchel D Flegel; Kevin Jeroncic; Yeping Xiong; Dean Cheng; Roman Eisner; Bijaya Gautam; Dan Tzur; Summit Sawhney; Fiona Bamforth; Russ Greiner; Liang Li
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-05-08       Impact factor: 3.205

5.  Exploring the precursor ion exclusion feature of liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun proteome analysis.

Authors:  Nan Wang; Liang Li
Journal:  Anal Chem       Date:  2008-05-15       Impact factor: 6.986

6.  The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).

Authors:  Therese Rosenling; Christiaan L Slim; Christin Christin; Leon Coulier; Shanna Shi; Marcel P Stoop; Jan Bosman; Frank Suits; Peter L Horvatovich; Norbert Stockhofe-Zurwieden; Rob Vreeken; Thomas Hankemeier; Alain J van Gool; Theo M Luider; Rainer Bischoff
Journal:  J Proteome Res       Date:  2009-12       Impact factor: 4.466

7.  Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.

Authors:  Marcel P Stoop; Leon Coulier; Therese Rosenling; Shanna Shi; Agnieszka M Smolinska; Lutgarde Buydens; Kirsten Ampt; Christoph Stingl; Adrie Dane; Bas Muilwijk; Ronald L Luitwieler; Peter A E Sillevis Smitt; Rogier Q Hintzen; Rainer Bischoff; Sybren S Wijmenga; Thomas Hankemeier; Alain J van Gool; Theo M Luider
Journal:  Mol Cell Proteomics       Date:  2010-09       Impact factor: 5.911

8.  Poly(ethylene glycol)-based stable isotope labeling reagents for the quantitative analysis of low molecular weight metabolites by LC-MS.

Authors:  Nicolas Abello; Paul P Geurink; Marco van der Toorn; Antoon J M van Oosterhout; Johan Lugtenburg; Gijs A van der Marel; Huib A M Kerstjens; Dirkje S Postma; Hermen S Overkleeft; Rainer Bischoff
Journal:  Anal Chem       Date:  2008-12-01       Impact factor: 6.986

9.  Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques.

Authors:  William R Wikoff; Gurudutt Pendyala; Gary Siuzdak; Howard S Fox
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

10.  A statistical procedure to selectively detect metabolite signals in LC-MS data based on using variable isotope ratios.

Authors:  Lung-Cheng Lin; Hsin-Yi Wu; Vincent Shin-Mu Tseng; Lien-Chin Chen; Yu-Chen Chang; Pao-Chi Liao
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-12       Impact factor: 3.109

View more
  17 in total

1.  Chemical Isotope Labeling LC-MS for Metabolomics.

Authors:  Shuang Zhao; Liang Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Isotopic labeling-assisted metabolomics using LC-MS.

Authors:  C Bueschl; R Krska; B Kluger; R Schuhmacher
Journal:  Anal Bioanal Chem       Date:  2012-09-26       Impact factor: 4.142

3.  Relative quantification of amine-containing metabolites using isobaric N,N-dimethyl leucine (DiLeu) reagents via LC-ESI-MS/MS and CE-ESI-MS/MS.

Authors:  Ling Hao; Xuefei Zhong; Tyler Greer; Hui Ye; Lingjun Li
Journal:  Analyst       Date:  2015-01-21       Impact factor: 4.616

4.  Comprehensive urinary metabolomic characterization of a genetically induced mouse model of prostatic inflammation.

Authors:  Ling Hao; Yatao Shi; Samuel Thomas; Chad M Vezina; Sagar Bajpai; Arya Ashok; Charles J Bieberich; William A Ricke; Lingjun Li
Journal:  Int J Mass Spectrom       Date:  2018-09-22       Impact factor: 1.986

5.  NMR based CSF metabolomics in tuberculous meningitis: correlation with clinical and MRI findings.

Authors:  Rashmi Parihar; Ruchi Shukla; Bikash Baishya; Jayantee Kalita; Rudrashish Haldar; Usha Kant Misra
Journal:  Metab Brain Dis       Date:  2022-01-14       Impact factor: 3.584

Review 6.  Isotope enhanced approaches in metabolomics.

Authors:  G A Nagana Gowda; Narasimhamurthy Shanaiah; Daniel Raftery
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 7.  Relative quantification of biomarkers using mixed-isotope labeling coupled with MS.

Authors:  Heidi M Chapman; Katherine L Schutt; Emily M Dieter; Shane M Lamos
Journal:  Bioanalysis       Date:  2012-10       Impact factor: 2.681

8.  Development of isotope labeling LC-MS for human salivary metabolomics and application to profiling metabolome changes associated with mild cognitive impairment.

Authors:  Jiamin Zheng; Roger A Dixon; Liang Li
Journal:  Anal Chem       Date:  2012-12-06       Impact factor: 6.986

9.  Biomarker Discovery and Translation in Metabolomics.

Authors:  G A Nagana Gowda; D Raftery
Journal:  Curr Metabolomics       Date:  2013

10.  Liquid chromatography/mass spectrometry methods for measuring dipeptide abundance in non-small-cell lung cancer.

Authors:  Manhong Wu; Yue Xu; William L Fitch; Ming Zheng; Robert E Merritt; Joseph B Shrager; Weiruo Zhang; David L Dill; Gary Peltz; Chuong D Hoang
Journal:  Rapid Commun Mass Spectrom       Date:  2013-09-30       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.